Medicare Enrolled
Dr. Samuel Myrick, MD
Medical Oncology · Ocala, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Myrick from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Myrick?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Myrick
Dr. Samuel Myrick is a medical oncology specialist in Ocala, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Myrick performed 90,343 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Myrick received a total of $28,869 from 103 pharmaceutical and/or device companies across 1344 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Myrick is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 27% volume in FL
$28,869 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 90579 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗90,343
Medicare services
Top 27% in FL for medical oncology
Not available
Unique patients (not deduplicated)
$12
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Filgrastim injection (Zarxio) for white blood cells An injection of the biosimilar medication filgrastim-sndz (Zarxio) with a dosage of 1 microgram. |
25,560 | $0 | $2 |
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
24,090 | $2 | $21 |
| Pembrolizumab injection (Keytruda) | 9,400 | $43 | $147 |
| Iron infusion (Monoferric) | 7,600 | $17 | $75 |
| Denosumab injection (Prolia/Xgeva) | 5,280 | $19 | $70 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
5,100 | $0 | $6 |
| Immune globulin infusion (Octagam) This procedure involves the administration of immune globulin medication directly into a vein. It is provided in a non-lyophilized liquid form. |
3,662 | $34 | $251 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
880 | $8 | $35 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
880 | $0 | $1 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
841 | $8 | $19 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
764 | $10 | $62 |
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
690 | $6 | $30 |
| Pegfilgrastim-apgf injection An injection of pegfilgrastim-apgf, a biosimilar medication. The dose specified is 0.5 mg. |
600 | $92 | $879 |
| Anti-nausea injection (Aloxi/palonosetron) | 550 | $1 | $122 |
| Injection, granisetron hydrochloride, 100 mcg | 420 | $0 | $25 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
380 | $11 | $93 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
352 | $94 | $224 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
336 | $12 | $105 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
329 | $64 | $149 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
198 | $99 | $686 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
184 | $47 | $304 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
180 | $13 | $58 |
| Iron level test | 179 | $6 | $26 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
179 | $9 | $34 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
128 | $15 | $74 |
| Folic acid level test A blood test that measures the amount of folic acid in the serum. |
123 | $14 | $71 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
105 | $16 | $97 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
99 | $6 | $30 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
93 | $64 | $157 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
91 | $1 | $7 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
84 | $1 | $19 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
78 | $24 | $249 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
73 | $1 | $19 |
| Immunoassay substance measurement A laboratory test that uses immunoassay techniques to measure the level of a specific substance in a sample. |
68 | $17 | $181 |
| Nephelometry test A laboratory test that uses light scattering to measure the concentration of specific substances in a sample. |
68 | $13 | $176 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
65 | $22 | $152 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
55 | $50 | $334 |
| PSA test (prostate cancer screening) | 54 | $18 | $91 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
50 | $2 | $19 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
47 | $17 | $111 |
| Platelet-associated immunoglobulin antibody test A laboratory test that identifies antibodies attached to platelets. It measures the amount of immunoglobulin associated with the patient's platelets. |
45 | $12 | $155 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
45 | $129 | $343 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
42 | $56 | $205 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
39 | $10 | $73 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
35 | $21 | $156 |
| Blood sample collection from implanted device This procedure involves drawing a blood sample directly from a medical device that has been surgically placed in the body. |
34 | $19 | $64 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 34 | $20 | $124 |
| Immunoglobulin light chain measurement A blood test that measures the levels of immunoglobulin light chains, which are proteins produced by plasma cells. |
30 | $17 | $60 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
26 | $65 | $214 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
21 | $1,205 | $4,120 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
18 | $29 | $240 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
17 | $75 | $251 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 16 | $410 | $638 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
14 | $19 | $96 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
12 | $106 | $297 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
13.4% high complexity
81.4% medium
5.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$28,869
Total received (2018-2024)
Avg $4,124/year across 7 years
Top 19% in FL for medical oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
103
Companies
1,344
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$6,574
2023
$4,411
2022
$4,349
2021
$3,612
2020
$2,443
2019
$4,082
2018
$3,399
Payments by company (2024)
Novartis Pharmaceuticals Corporation
$1,423
PFIZER INC.
$784
Celgene Corporation
$395
Astellas Pharma US Inc
$392
Takeda Pharmaceuticals U.S.A., Inc.
$268
Janssen Biotech, Inc.
$264
AstraZeneca Pharmaceuticals LP
$227
Genmab U.S., Inc.
$226
Merck Sharp & Dohme LLC
$193
E.R. Squibb & Sons, L.L.C.
$153
Amgen Inc.
$150
GlaxoSmithKline, LLC.
$143
Incyte Corporation
$141
ABBVIE INC.
$136
GENZYME CORPORATION
$121
Mirati Therapeutics, Inc.
$113
Regeneron Healthcare Solutions, Inc.
$94
Novocure Inc.
$89
Lilly USA, LLC
$83
Ipsen Biopharmaceuticals, Inc
$71
Bayer Healthcare Pharmaceuticals Inc.
$71
TAIHO ONCOLOGY, INC.
$68
Eisai Inc.
$67
Alexion Pharmaceuticals, Inc.
$62
SERVIER PHARMACEUTICALS LLC
$61
Dendreon Pharmaceuticals LLC
$60
Gilead Sciences, Inc.
$58
Daiichi Sankyo Inc.
$57
Pharmacosmos Therapeutics Inc.
$56
JAZZ PHARMACEUTICALS INC.
$55
PharmaEssentia USA Corporation
$48
Boehringer Ingelheim Pharmaceuticals, Inc.
$47
EMD Serono, Inc.
$43
Aveo Pharmaceuticals, Inc.
$38
TerSera Therapeutics LLC
$34
SOBI, INC
$30
CSL Behring
$26
Fennec Pharmaceuticals, Inc.
$24
Tempus AI, Inc
$23
Rigel Pharmaceuticals, Inc.
$22
Genentech USA, Inc.
$21
Agios Pharmaceuticals, Inc.
$19
Apellis Pharmaceuticals, Inc.
$19
Geron Corporation
$19
Blueprint Medicines Corporation
$18
BeiGene USA, Inc.
$17
Stemline Therapeutics Inc.
$17
ARRAY BIOPHARMA INC
$14
Coherus Biosciences Inc.
$14
Top 3 companies account for 39.6% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$2,627
Janssen Biotech, Inc.
$1,756
PFIZER INC.
$1,679
AstraZeneca Pharmaceuticals LP
$1,498
Amgen Inc.
$1,170
E.R. Squibb & Sons, L.L.C.
$1,092
Astellas Pharma US Inc
$1,015
Incyte Corporation
$786
Lilly USA, LLC
$755
Celgene Corporation
$741
Seagen Inc.
$737
Merck Sharp & Dohme Corporation
$702
Merck Sharp & Dohme LLC
$675
Daiichi Sankyo Inc.
$634
Ipsen Biopharmaceuticals, Inc
$575
GENZYME CORPORATION
$535
GlaxoSmithKline, LLC.
$534
Genentech USA, Inc.
$510
Bayer HealthCare Pharmaceuticals Inc.
$488
Takeda Pharmaceuticals U.S.A., Inc.
$481
Kite Pharma, Inc.
$444
Regeneron Healthcare Solutions, Inc.
$425
Pharmacyclics LLC, An AbbVie Company
$389
EMD Serono, Inc.
$376
Genmab U.S., Inc.
$352
Seattle Genetics, Inc.
$352
Eisai Inc.
$307
Rigel Pharmaceuticals, Inc.
$297
Octapharma USA, Inc.
$295
Boehringer Ingelheim Pharmaceuticals, Inc.
$274
JAZZ PHARMACEUTICALS INC.
$273
EISAI INC.
$267
TESARO, Inc.
$255
Puma Biotechnology, Inc.
$254
Gilead Sciences, Inc.
$227
SERVIER PHARMACEUTICALS LLC
$197
Karyopharm Therapeutics Inc.
$191
Alexion Pharmaceuticals, Inc.
$190
Bayer Healthcare Pharmaceuticals Inc.
$189
Janssen Scientific Affairs, LLC
$183
Jazz Pharmaceuticals Inc.
$181
ARRAY BIOPHARMA INC
$168
Mirati Therapeutics, Inc.
$164
ABBVIE INC.
$158
Clovis Oncology, Inc.
$148
G1 Therapeutics, Inc.
$137
Stemline Therapeutics Inc.
$132
BeiGene USA, Inc.
$131
Pharmacosmos Therapeutics Inc.
$127
Dova Pharmaceuticals
$126
MorphoSys, US Inc.
$117
Foundation Medicine, Inc.
$117
TerSera Therapeutics LLC
$102
Ethicon US, LLC
$101
CTI BioPharma Corp.
$97
Novocure Inc.
$89
PharmaEssentia USA Corporation
$85
Apellis Pharmaceuticals, Inc.
$83
Agios Pharmaceuticals, Inc.
$80
Heron Therapeutics, Inc.
$79
Servier Pharmaceuticals LLC
$78
Deciphera Pharmaceuticals Inc.
$74
Pharmacyclics LLC, an AbbVie Company
$74
PUMA BIOTECHNOLOGY, INC.
$71
TAIHO ONCOLOGY, INC.
$68
TG THERAPEUTICS, INC.
$65
MEDIVATION FIELD SOLUTIONS LLC
$63
CSL Behring
$63
SOBI, INC
$60
Taiho Oncology, Inc.
$60
Dendreon Pharmaceuticals LLC
$60
ADC Therapeutics America, Inc.
$57
Exelixis Inc.
$55
Sun Pharmaceutical Industries Inc.
$53
Epizyme, Inc.,
$52
Aveo Pharmaceuticals, Inc.
$51
AbbVie Inc.
$48
Blueprint Medicines Corporation
$48
Astellas Pharma Global Development
$48
Global Blood Therapeutics, Inc.
$48
Array BioPharma Inc.
$39
Immunocore Limited
$36
Secura Bio, Inc.
$36
Kyowa Kirin, Inc.
$33
AVEO Pharmaceuticals, Inc.
$31
Teva Pharmaceuticals USA, Inc.
$30
Helsinn Therapeutics (U.S.), Inc.
$25
Fennec Pharmaceuticals, Inc.
$24
Tempus AI, Inc
$23
TG Therapeutics, Inc.
$23
Acrotech Biopharma Inc.
$20
AbbVie, Inc.
$20
Medtronic, Inc.
$20
Advanced Accelerator Applications
$19
Lexicon Pharmaceuticals, Inc.
$19
Geron Corporation
$19
TOLMAR Pharmaceuticals, Inc.
$18
Emmaus Medical, Inc.
$17
Alnylam Pharmaceuticals Inc.
$17
Grifols USA, LLC
$16
Collegium Pharmaceutical, Inc.
$15
Coherus Biosciences Inc.
$14
GE HEALTHCARE
$10
Top 3 companies account for 21.0% of all-time payments
Associated products mentioned in payments ›
ABECMA · ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · ALUNBRIG · AUGTYRO · AYVAKIT · Afstyla · Alecensa · Aliqopa · Aranesp · Avastin · BALVERSA · BAVENCIO · BELEODAQ · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Balversa · Bavencio · Blincyto · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · CERDELGA · CERTUS 140 MICROWAVE ABLATION SYSTEM · CINVANTI · COSELA · CYRAMZA · Cabometyx · Cinvanti · Creon · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIGARD · ELITEK · ELREXFIO · EMPRINT · ENHERTU · ENJAYMO · ERBITUX · ERLEADA · EVENITY · EXKIVITY · Empaveli · Endari · Enhertu · Epkinly · Erleada · FARYDAK · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · Farydak · GAZYVA · GILOTRIF · GIVLAARI · Gamunex-C · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INFUGEM · INJECTAFER · INLYTA · INREBIC · Imbruvica · Inrebic · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KIMMTRAK · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lunsumio · Lutathera · MEKINIST · MEKTOVI · MONJUVI · MONOFERRIC · MVASI · MYLOTARG · NERLYNX · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ODOMZO (sonidegib) capsules · OJJAARA · ONIVYDE · OPDIVO · OPDUALAG · OXBRYTA · Oncaspar · Onivyde · Optune Lua (NovoTTF-200T) · Orserdu · PADCEV · PANZYGA · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PROSTATE CANCER - DISEASE · PROVENGE · PYRUKYND · Padcev · Pedmark · Perjeta · Polivy · Pomalyst · Prolia · QINLOCK · Quzyttir · REBLOZYL · RECOTHROM · RETEVMO · RYBREVANT · RYTELO · Revlimid · Rezlidhia · Rubraca · SARCLISA · SCEMBLIX · SHINGRIX · SOLIRIS · SOMATULINE DEPOT · SUTENT · Somatuline Depot · Stivarga · TAFINLAR · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tibsovo · Trodelvy · UKONIQ · ULTOMIRIS · Udenyca · Ultomiris · VENCLEXTA · VERZENIO · VOTRIENT · VYXEOS · Vectibix · Venclexta · Vitrakvi · Vonjo · XALKORI · XGEVA · XOSPATA · XPOVIO · XT CDX · XTAMPZA · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · YONSA (abiraterone acetate) · Yescarta · ZEJULA · ZEPZELCA · ZOLADEX · Zoladex
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Medical oncologists in nearby ZIP areas
6
County median income
$58,535
Nearest hospital to ZIP centroid (approximate)
ADVENTHEALTH OCALA
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Myrick is a mixed practice specialist, with above-average Medicare volume (top 27% in FL), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Myrick experienced with filgrastim injection (zarxio) for white blood cells?
Based on Medicare claims data, Dr. Myrick performed 25,560 filgrastim injection (zarxio) for white blood cells services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Myrick receive payments from pharmaceutical companies?
Yes. Dr. Myrick received a total of $28,869 from 103 companies across 1,344 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Myrick's costs compare to other medical oncologists in Ocala?
Dr. Myrick's average Medicare payment per service is $12. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Myrick) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologists in Ocala
Browse medical oncologists in Ocala ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologists in FL
Medical oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologists in FL
Which FL medical oncologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology